Advent Life Sciences Growth Fund LP
Advent Life Sciences Growth Fund LP is a venture capital fund based in London, United Kingdom. According to its most recent Form D, filed Nov 7, 2025, it has sold $9,800,250 of interests to 1 investor since its first sale in Oct 2024. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, AltMountain classifies it as an emerging manager. Related persons named in the filing include Rajesh Parekh; Dominic Schmidt; Shahzad Malik.
- Total raised
- $9,800,250Cumulative sales reported on Form D
- Investors
- 1
- First sale
- Oct 14, 2024
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Rajesh Parekh; Dominic Schmidt; Shahzad Malik
- Latest Form D
- Nov 7, 2025
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Advent Life Sciences Growth Fund LP
What is the minimum investment for Advent Life Sciences Growth Fund LP?
Advent Life Sciences Growth Fund LP's latest Form D, filed Nov 7, 2025, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Advent Life Sciences Growth Fund LP?
Advent Life Sciences Growth Fund LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Advent Life Sciences Growth Fund LP raised?
Advent Life Sciences Growth Fund LP reports $9,800,250 sold from 1 investor on its Form D filed Nov 7, 2025. This is cumulative sales since the offering began, not current assets or performance.
Where is Advent Life Sciences Growth Fund LP based?
Advent Life Sciences Growth Fund LP is based in London, United Kingdom and is managed by Advent Life Sciences LLP.
When did Advent Life Sciences Growth Fund LP launch?
Advent Life Sciences Growth Fund LP reports its first sale in Oct 2024, which makes it an emerging manager by AltMountain's definition (first sale in 2021 or later and under $50 million raised).
Size compared with every venture capital fund
Raised more than 51% of the 39 venture capital funds based in United Kingdom, and more than 87% of all 15,160 that report sales.